Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q1 FY22 results · Apr–Jun 2021

Advanced Enzyme Technologies reported revenue from operations of ₹137.01 crore (up 24.0% from Q1 FY21) and net profit of ₹39.86 crore (up 14.5% from Q1 FY21) for Q1 FY22 (Apr–Jun 2021), on a consolidated basis.

Consolidated · ₹ crore
ItemQ1 FY22Q1 FY21YoYQ4 FY21QoQ
Revenue from operations137.01110.50+24.0%133.22+2.9%
Other income0.935.23−82.2%1.68−44.6%
Total income137.95115.73+19.2%134.90+2.3%
Profit before tax54.9349.78+10.3%47.77+15.0%
Net profit for the period39.8634.80+14.5%33.80+17.9%
Attributable to shareholders of the company38.0434.25+11.1%31.68+20.1%
EPS, basic (₹)3.403.07+10.7%2.84+19.7%
Net margin (%)29.131.525.4
Standalone · ₹ crore
ItemQ1 FY22Q1 FY21YoYQ4 FY21QoQ
Revenue from operations72.7561.41+18.5%70.61+3.0%
Other income0.940.73+29.4%2.58−63.5%
Total income73.6962.13+18.6%73.19+0.7%
Profit before tax25.0921.73+15.4%22.07+13.7%
Net profit for the period18.5515.32+21.1%15.24+21.7%
EPS, basic (₹)1.661.37+21.2%1.37+21.2%
Net margin (%)25.525.021.6
Consolidated
Filed with BSE
07 Aug 2021, 17:47 IST
Board meeting
07 Aug 2021
Period
01 Apr 2021 to 30 Jun 2021
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
07 Aug 2021, 17:47 IST
Board meeting
07 Aug 2021
Period
01 Apr 2021 to 30 Jun 2021
Review status
Unaudited
Source
XBRL filing on BSE